Consistent with the immunoblotting results, emodin alone or combined with gemcitabine decreased the DNA binding activity of NF-κB in pancreatic cancer orthotopically implanted with Panc-1 cells (Fig. 9A, B). This evidence concerns the gene NFKB1 and pancreatic neoplasm.